Across our laboratories and clinics, faculty are driving discovery - from pioneering research on the role of microglia in Alzheimer’s disease and breakthroughs in rare disease gene identification, to first-in-human gene therapy trials and the use of artificial intelligence to accelerate diagnostics and drug discovery. Our translational focus remains a hallmark: moving seamlessly from bench to bedside to ensure that even the rarest patients are not left behind.
This issue also introduces new faculty leaders and program launches, including our growing efforts in integrative microbiome research and initiatives designed to intercept disease before symptoms appear. These stories reflect not only scientific excellence but also our commitment to collaboration, patient-centered care, and health equity.
Together, we are shaping a future where genetic and genomic science delivers not just answers, but actionable solutions - tailored to the individual, and informed by data, discovery, and compassion.